Article, 2024
Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks
Expert Review of Clinical Pharmacology,
ISSN
1751-2433,
1751-2441,
Volume 17,
5-6,
Pages 433-440,
10.1080/17512433.2024.2355270
Contributors
Mcdonald, Emily Gibson
0000-0003-0783-0624
(Corresponding author)
[1]
[2]
Lundby, Carina
0000-0002-2121-6252
[3]
[4]
Thompson, Wade
0000-0002-8268-4092
[5]
Boyd, Cynthia Melinda
[6]
Farrell, Barbara J
0000-0002-2388-5353
[7]
Gagnon, Camille L
0000-0003-4576-6336
[1]
Herbin, Jennie
[1]
[2]
Khuong, Ninh Viet
[1]
Moriarty, Frank
0000-0001-9838-3625
[8]
Pierson, Tiphaine
[1]
[2]
Scott, Sion
0000-0001-7669-0632
[9]
Scott, Ian A.
[10]
Silvius, Jim
[1]
[10]
[11]
Spinewine, Anne
0000-0002-3836-2846
[12]
Steinman, Michael Alan
0000-0002-9564-9480
[13]
Tannenbaum, Cara Beth
[1]
[14]
Trimble, Johanna
[1]
Turner, Justin Paul
0000-0003-0613-108X
[15]
Reeve, Emily
0000-0002-1405-999X
[15]
[16]
Affiliations
- [1]
Canadian Medication Appropriateness and Deprescribing Network, Montreal, Quebec, Canada
[NORA names:
Canada; America, North; OECD];
- [2]
McGill University Health Centre
[NORA names:
Canada; America, North; OECD];
- [3]
Odense University Hospital
[NORA names:
Region of Southern Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
- [4]
University of Southern Denmark
[NORA names:
SDU University of Southern Denmark; University; Denmark; Europe, EU; Nordic; OECD];
- [5]
University of British Columbia
[NORA names:
Canada; America, North; OECD];
(... more)
- [6]
Johns Hopkins University
[NORA names:
United States; America, North; OECD];
- [7]
University of Ottawa
[NORA names:
Canada; America, North; OECD];
- [8]
Royal College of Surgeons in Ireland
[NORA names:
Ireland; Europe, EU; OECD];
- [9]
University of Leicester
[NORA names:
United Kingdom; Europe, Non-EU; OECD];
- [10]
University of Calgary
[NORA names:
Canada; America, North; OECD];
- [11]
Alberta Health Services
[NORA names:
Canada; America, North; OECD];
- [12]
Louvain Drug Research Institute, Clinical Pharmacy Research Group UCLouvain, Brussels, Belgium
[NORA names:
Belgium; Europe, EU; OECD];
- [13]
University of California, San Francisco
[NORA names:
United States; America, North; OECD];
- [14]
University of Montreal
[NORA names:
Canada; America, North; OECD];
- [15]
Monash University
[NORA names:
Australia; Oceania; OECD];
- [16]
University of South Australia
[NORA names:
Australia; Oceania; OECD]
(less)
Abstract
INTRODUCTION: Over the past decade, polypharmacy has increased dramatically. Measurable harms include falls, fractures, cognitive impairment, and death. The associated costs are massive and contribute substantially to low-value health care. Deprescribing is a promising solution, but there are barriers. Establishing a network to address polypharmacy can help overcome barriers by connecting individuals with an interest and expertise in deprescribing and can act as an important source of motivation and resources.
AREAS COVERED: Over the past decade, several deprescribing networks were launched to help tackle polypharmacy, with evidence of individual and collective impact. A network approach has several advantages; it can spark interest, ideas and enthusiasm through information sharing, meetings and conversations with the public, providers, and other key stakeholders. In this special report, the details of how four deprescribing networks were established across the globe are detailed.
EXPERT OPINION: Networks create links between people who lead existing and/or budding deprescribing practices and policy initiatives, can influence people with a shared passion for deprescribing, and facilitate sharing of intellectual capital and tools to take initiatives further and strengthen impact.This report should inspire others to establish their own deprescribing networks, a critical step in accelerating a global deprescribing movement.
Keywords
approach,
barriers,
capital,
care,
cognitive impairment,
conversion,
cost,
cover,
death,
deprescribing,
deprescribing practices,
enthusiasm,
evidence,
expertise,
fracture,
globe,
harm,
health,
health care,
ideas,
impact,
impairment,
inappropriate polypharmacy,
individuals,
influence people,
information,
information sharing,
initiation,
intellectual capital,
interest,
international level,
levels,
measuring harm,
meeting,
motivation,
movement,
network,
network approach,
overcome barriers,
passion,
people,
policy,
policy initiatives,
polypharmacy,
practice,
providers,
publications,
reports,
resources,
sharing,
sharing of intellectual capital,
solution,
source,
source of motivation,
spark interest,
stakeholders,
tools
Data Provider: Digital Science